Visit Boston Scientific’s suite at VIVA for a hands-on experience with our next generation of drug-elution, critical limb ischemia, and venous technologies. Explore product prototypes and learn about the science behind these future therapy options. Plus, join the conversation with peripheral vascular leaders at our Expert Roundtable Series.
Visit Boston Scientific’s suite for a hands-on experience with our future of drug-elution, critical limb ischemia, and venous technologies.
|The Future of Drug-Elution: The Eluvia™ Drug-Eluting Vascular Stent is the first and only DES designed to sustain drug release beyond one year. Boston Scientific is investing to be at the forefront of drug-eluting innovation, and will be the first and only company to offer both a DES and DCB for SFA interventions.|
|The Future of Critical Limb Ischemia Therapy: Boston Scientific is investing to develop a drug-eluting stent purpose-built for below-the-knee disease with extended drug release, exceptional radial force, and a broad size matrix to address your most challenging CLI cases.|
|The Future of Venous Technologies: Boston Scientific is building upon its expertise in PTA balloons by developing a portfolio of large diameter, high pressure, and ultra-non-compliant balloons specifically designed for the venous system.|
Come see other key innovations, including next-generation above- and below-the-knee atherectomy devices, intravascular ultrasound (IVUS) and thrombectomy.
Lunch Symposium at VEINS
Interventions for Iliofemoral DVT: What’s Next?
Sunday, September 10, 2017 | Petrus 1 | 12:00 – 1:10 pm
Evolving Perspectives on DVT Diagnosis, Treatment and Patient Care
- Mitchell Silver, DO -
Progressive Strategies for Patient Management in My DVT Practice
- Kush Desai, MD -
Contemporary DVT Treatment Techniques: Pharmacomechanical Thrombectomy
- David O’Connor, MD -
VIVA Lunch Symposium in Partnership with Siemens Healthineers
Complex PAD: Evidence, Experience, and Economics
Tuesday, September 12, 2017 | Mouton2 | 12:00–1:10 pm
Experience with Vessel Prep & Drug Eluting Therapies
- Christopher Metzger, MD -
Extravascular Ultrasound to Treat Complex PAD
- Fadi Saab, MD -
Health Economics of Drug-Eluting Therapy: European Experience
- Konstantino Katsanos, MD -
VIVA Lunch Symposium
Beyond Devices: The Future of CLI Treatment
Wednesday, September 13 , 2017 | Margaux 2 | 12:00–1:10 pm
Taking Leadership in the Full Care Continuum for CLI Patients
- Lawrence Garcia, MD -
Understanding the Disease: Latest Research Findings on Pathophysiology and Progression in CLI Patients | Treatment for the Future CLI Patient: DES Below-the-Knee
- Jihad Mustapha, MD -
The Care Continuum for the Future CLI Patient: Ways Physicians & Industry Can Collaborate to Make an Impact
- Miguel Montero-Baker, MD -
Tuesday, September 12, 2017
What’s Next for DVT?
Dr. Hooman Madyoon
Office-Based Labs – Best Practices & Trends
Dr. Joseph Hewett
Wednesday, September 13, 2017
Social Media for the Interventionalist
Dr. Fadi Saab